VISCHER has advised Proteomedix AG on its licensing agreement with Immunovia AB. Proteomedix AG, a Swiss biotech subsidiary of Onconetix, Inc., has entered into a licensing...
You must be a Standard 1 Year member to access this content.
VISCHER has advised CARAUKTION. AutoScout24 has completed the acquisition of the consumer-to-business (C2B) segment previously developed in partnership with CARAUKTION, including the C2B auction platform. Effective...
You must be a Standard 1 Year member to access this content.
VISCHER has advised Medartis. Medartis, a Basel-based orthopedic company listed on the SIX Swiss Exchange, has acquired the remaining 53% stake in Geneva-based KeriMedical SA, making...
You must be a Standard 1 Year member to access this content.
VISCHER has advised Earlybird Health, Wellington Partners, Kfund, and naturalX Health Ventures. Aktiia, a company specializing in blood pressure intelligence technology, has successfully raised USD 42...
You must be a Standard 1 Year member to access this content.
